Zymeworks Highlights Promising Zanidatamab Data Across HER2+ Cancers at Upcoming AACR Meeting
Market Chameleon (Wed, 18-Mar 7:53 AM)
Zymeworks Highlights New Ziihera Data to Broaden HER2 Cancer Reach
at www.tipranks.com (Wed, 18-Mar 8:23 AM)
Zymeworks Highlights ADC and Novel Pan-RAS Platform Data Ahead of AACR Meeting
at www.tipranks.com (Tue, 17-Mar 5:46 PM)
